Anti Retroviral Therapy.
The World Health Organisation (WHO), in its recent ‘Treat Ali’ recommendation, removed all the limitations on eligibility for Anti Retroviral Therapy (ART) among people living with HIV. With this, all age groups will now be eligible for treatment. The expanded use of antiretroviral treatment is supported by recent findings from clinical trials confirming that early use of ART keeps people living with HIV alive, healthier and reduces the risk of transmitting the virus to partners. The recommendations were developed as part of a The World Health Organisation (WHO), in its recent ‘Treat Ali’ recommendation, removed all the limitations on eligibility for Anti Retroviral Therapy (ART) among people living with HIV. With this, all age groups will now be eligible for treatment. The expanded use of antiretroviral treatment is supported by recent findings from clinical trials confirming that early use of ART keeps people living with HIV alive, healthier and reduces the risk of transmitting the virus to partners. The recommendations were developed as part of a comprehensive update of the WHO consolidated guidelines on the use of anti retroviral drugs for preventing and treating HIV infection. This new recommendation follows up the 2014 WHO guidance that offered a combination of anti retroviral drugs to prevent HIV acquisition.
Article By Pratham Sharma.
0 Comments
Please Comment Down Below